Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K043179
    Date Cleared
    2005-02-08

    (83 days)

    Product Code
    Regulation Number
    870.4210
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K013013, K033416

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    These cannulae are intended for use in perfusion of the ascending aorta during short term (6 hours or less) cardiopulmonary bypass.

    Device Description

    The Select 3D™ Arterial Cannulae both have clear flexible, thin wall wire-wound PVC bodies with angled, beveled tips. The proximal end of the cannula includes a 3/8" (0.95 cm) vented or non-vented connector with a peel cap. The vented connector allows air to be vented from the cannula before connection to the perfusion line. The Select 3D™ Arterial Cannula tip has three integrated flutes which help diffuse and disperse blood flow. The cannula body features a tip orientation line indicating direction of the cannula tip during cannulation. Overall cannula length is 11.5" (29.2 cm). The new sizes are 18 and 20 Fr. The Cannulae are available uncoated or with a Carmeda® Coating.

    AI/ML Overview

    The provided text is a 510(k) summary for the Medtronic Select 3D™ Arterial Cannula. It describes a medical device, its intended use, and a comparison to predicate devices, along with a summary of performance data.

    Here's an analysis of the acceptance criteria and study information based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategoryReported Device Performance
    Dimensional TestingAll testing passed.
    Functional TestingAll testing passed.
    BiocompatibilityNot affected by the changes in the device.
    SterilizationNot affected by the changes in the device.
    PackagingNot affected by the changes in the device.
    Accelerated Aged Dimensional TestingPerformed as well as flow and hemolysis characterization. All testing passed.
    Accelerated Aged Functional TestingPerformed as well as flow and hemolysis characterization. All testing passed.
    Flow CharacterizationPerformed. All testing passed.
    Hemolysis CharacterizationPerformed. All testing passed.
    Carmeda® Coating AbilityTested. All testing passed.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: The document does not specify the exact sample size for the "in vitro dimensional and functional testing," "accelerated aged dimensional and functional testing," "flow and hemolysis characterization," or the "Carmeda® Coating ability" tests. It only states that these tests were performed and "All testing passed."
    • Data Provenance: The studies were in vitro (laboratory-based) tests. The country of origin for the data is not explicitly stated but implies the studies were conducted by Medtronic Perfusion Systems in the USA, as they are the submitter located in Minnesota. The studies were prospective as they were conducted to validate the new device sizes.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This type of information is not applicable to this submission. The "ground truth" for this device validation is based on engineering specifications, material properties, and performance standards for in vitro testing, not expert interpretation of medical images or clinical outcomes. The tests evaluate physical and functional characteristics against predetermined engineering benchmarks.

    4. Adjudication Method for the Test Set

    This is not applicable as the validation did not involve subjective interpretation or a need for reconciliation of expert opinions. The tests were objective measurements against predefined acceptance criteria.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, a MRMC comparative effectiveness study was not done. The submission is for a medical device (cannula) and focuses on its physical and functional performance, not on diagnostic accuracy requiring human reader judgment.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This question is not applicable as the device is a physical medical cannula, not an algorithm or AI system. The validation focuses on the device's intrinsic physical properties and performance in an in vitro setting.

    7. The Type of Ground Truth Used

    The "ground truth" for this device validation involved engineering specifications, material specifications, and established performance benchmarks for flow characteristics, hemolysis, dimensional accuracy, and durability (accelerated aging). It is based on objective, measurable physical and functional properties, rather than pathology, outcomes data, or expert consensus in a medical diagnostic context.

    8. The Sample Size for the Training Set

    This question is not applicable as the device is a physical medical product, not an AI or machine learning model that requires a training set. The "training" in this context refers to the manufacturing and design processes, which are guided by established engineering principles and prior device knowledge, rather than a data-driven training set.

    9. How the Ground Truth for the Training Set Was Established

    This question is not applicable for the same reasons as point 8. The "ground truth" is inherent in the established engineering and design principles, and the performance of the predicate devices. The new cannulae were developed based on the known successful design and performance of the predicate devices, simply differing in diameter.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1